Epimax Ointment

Epimax is a well-established brand in the UK dermatological market, known for its range of emollients designed to manage dry skin conditions such as eczema and psoriasis. The brand was developed with a focus on providing cost-effective, high-quality alternatives to traditional emollient brands, making it a staple in both National Health Service (NHS) prescribing and over-the-counter sales.

The Epimax brand is owned and manufactured by Aspire Pharma Limited, an independent British pharmaceutical company. Aspire Pharma has grown rapidly since its inception, specializing in a variety of therapeutic areas including dermatology, ophthalmology, and urology. The manufacturing of the Epimax range is primarily localized within the United Kingdom to ensure high standards of quality control and supply chain efficiency.

In 2021, Aspire Pharma underwent a significant ownership change when it was acquired by the global investment firm H.I.G. Capital. This partnership was intended to accelerate Aspire's Growth through the development of new products and expansion into international markets, particularly across Europe. Despite this acquisition, the company remains headquartered and operational in the United Kingdom under its established management team.